Glial Cells: The Overlooked Orchestrators of Neurodegeneration and Chronic Pain
A comprehensive review in the Journal of Neurochemistry synthesizes recent advances in understanding glial cell plasticity and dysfunction in neurodegenerative diseases. The article details how astrocytes, microglia, and oligodendrocytes contribute to central nervous system homeostasis and, when dysregulated, drive pathology in conditions like Alzheimer’s and Parkinson’s disease. Key mechanisms include metabolic dysfunction, inflammatory polarization, and extracellular vesicle-mediated signaling, which propagate damage. The review critically evaluates emerging glia-targeted therapeutic strategies, such as cell reprogramming, senolytic therapies, and engineered extracellular vesicles, highlighting their potential to restore neural homeostasis and mitigate disease progression in chronic neurological disorders.
Study Significance: For rheumatologists managing conditions like fibromyalgia and chronic pain syndromes, this research underscores the critical role of non-neuronal cells in sustaining pain pathways and central sensitization. Understanding glial-immune crosstalk provides a mechanistic bridge between systemic inflammation seen in autoimmune diseases and persistent neurological symptoms, informing a more holistic treatment paradigm. This shifts the therapeutic focus beyond neuronal targets, suggesting that modulating glial cell activity could be a viable strategy for managing refractory chronic pain components in rheumatologic practice.
Source →Stay curious. Stay informed — with Science Briefing.
This is a one time Briefing, Upgrade to continue.
Upgrade and get 50% Off — Coupon: ERWMCWYU
